Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma von Ahluwalia, Manmeet S, Reardon, David A, Abad, Ajay P, Curry, William T, Wong, Eric T, Figel, Sheila A, Mechtler, Laszlo L, Peereboom, David M, Hutson, Alan D, Withers, Henry G, Liu, Song, Belal, Ahmed N, Qiu, Jingxin, Mogensen, Kathleen M, Dharma, Sanam S, Dhawan, Andrew, Birkemeier, Meaghan T, Casucci, Danielle M, Ciesielski, Michael J, Fenstermaker, Robert A

Volltext

Sellar and Parasellar Pain Syndromes von Abad, Ajay P.

Volltext

Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma von Zhang, Jeff F., Okai, Bernard, Iovoli, Austin, Goulenko, Victor, Attwood, Kristopher, Lim, Jaims, Hess, Ryan M., Abad, Ajay P., Prasad, Dheerendra, Fenstermaker, Robert A.

Volltext

Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma von Ciesielski, Michael J, Ahluwalia, Manmeet Singh, Reardon, David A., Abad, Ajay P., Curry, William T., Wong, Eric T., Peereboom, David M., Figel, Sheila A., Hutson, Alan, Groman, Adrienne, Withers, Henry G., Liu, Song, Belal, Ahmed, Qiu, Jing-Xin, Mogensen, Kathleen, Schilero, Cathy, Casucci, Danielle M., Mechtler, Laszlo, Fenstermaker, Robert Alan

Volltext

SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update von Ahluwalia, Manmeet Singh, Reardon, David A., Abad, Ajay P, Curry, William T., Wong, Eric T., Belal, Ahmed, Qiu, Jingxin, Mogensen, Kathleen, Schilero, Cathy, Hutson, Alan, Casucci, Danielle, Mechtler, Laszlo, Uhlmann, Erik J, Ciesielski, Michael J, Fenstermaker, Robert

Volltext

Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma von Ahluwalia, Manmeet Singh, Reardon, David A., Abad, Ajay P, Curry, William T., Wong, Eric T., Belal, Ahmed, Qiu, Jingxin, Mogensen, Kathleen, Schilero, Cathy, Casucci, Danielle, Mechtler, Laszlo, Uhlmann, Erik J, Ciesielski, Michael J, Fenstermaker, Robert

Volltext